Please note: In order to keep Hive up to date and provide users with the best features, we are no longer able to fully support Internet Explorer. The site is still available to you, however some sections of the site may appear broken. We would encourage you to move to a more modern browser like Firefox, Edge or Chrome in order to experience the site fully.

Key Statistical Concepts in Clinical Trials for Pharma, PDF eBook

Key Statistical Concepts in Clinical Trials for Pharma PDF

Part of the SpringerBriefs in Pharmaceutical Science & Drug Development series

PDF

Please note: eBooks can only be purchased with a UK issued credit card and all our eBooks (ePub and PDF) are DRM protected.

Description

This Brief discusses key statistical concepts that facilitate the inferential analysis of data collected from a group of individuals participating in a pharmaceutical clinical trial, the estimation of their clinical significance in the general population of individuals likely to be prescribed the drug if approved, and the related decision-making that occurs at both the public health level (by regulatory agencies when deciding whether or not to approve a new drug for marketing) and the individual patient level (by physicians and their patients when deciding whether or not the patient should be prescribed a drug that is on the market).

These concepts include drug safety and efficacy, statistical significance, clinical significance, and benefit-risk balance.

Information

Information

Also in the SpringerBriefs in Pharmaceutical Science & Drug Development series  |  View all